Atlas Trials

Continuous Hemodialysis With an Enhanced Middle Molecule Clearance Membrane

Clinical trial NCT01067313 · COMPLETED

Trial details

NCT number
NCT01067313
Sponsor
Fresenius Medical Care France
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Septic Shock
Start date
2008-07-01
Primary completion
2010-07-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.